| Dr Azra A Farooqui, MD | |
|
7745 Jewelweed Ct, Springfield, VA 22152-3148 | |
| (703) 569-3593 | |
| Not Available |
| Full Name | Dr Azra A Farooqui |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 7745 Jewelweed Ct, Springfield, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366621351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD036804 (District Of Columbia) | Primary |
| Entity Name | Fairfax County, Virginia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154356244 PECOS PAC ID: 9739136847 Enrollment ID: O20210319001688 |
News Archive
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
For their ability to differentiate into other cell types, the embryonic stem cells hold a large potential in the medical industry. Their use, however, poses ethical questions due to the fact that in order to obtain them, it is necessary to destroy the embryo. For this reason, medical researches use the so-called induced pluripotent stem cells (iPSC). In fact, it is possible to reprogram adult cells that can be obtained by simply drawing blood and making them "regress" to a similar state to that of embryonic stem cells.
Pregnant mice fed a diet high in omega-6 fats and low in omega-3 fats produce offspring that go on to exhibit "hedonic"—pleasurable but excessive—levels of consumption of hyper-caloric diets, according to researchers at Hiroshima University
MedRisk, Inc., the workers' compensation industry leader in specialty managed care services, has announced the creation of its Risk Information and Business Intelligence (RIBI) unit. RIBI's first initiative is to roll out a new reporting platform featuring state-of-the-art graphics and outcomes analytics.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Azra A Farooqui, MD 7745 Jewelweed Ct, Springfield, VA 22152-3148 Ph: (703) 569-3593 | Dr Azra A Farooqui, MD 7745 Jewelweed Ct, Springfield, VA 22152-3148 Ph: (703) 569-3593 |
News Archive
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
For their ability to differentiate into other cell types, the embryonic stem cells hold a large potential in the medical industry. Their use, however, poses ethical questions due to the fact that in order to obtain them, it is necessary to destroy the embryo. For this reason, medical researches use the so-called induced pluripotent stem cells (iPSC). In fact, it is possible to reprogram adult cells that can be obtained by simply drawing blood and making them "regress" to a similar state to that of embryonic stem cells.
Pregnant mice fed a diet high in omega-6 fats and low in omega-3 fats produce offspring that go on to exhibit "hedonic"—pleasurable but excessive—levels of consumption of hyper-caloric diets, according to researchers at Hiroshima University
MedRisk, Inc., the workers' compensation industry leader in specialty managed care services, has announced the creation of its Risk Information and Business Intelligence (RIBI) unit. RIBI's first initiative is to roll out a new reporting platform featuring state-of-the-art graphics and outcomes analytics.
› Verified 1 days ago
Dr. Cynthia M. Shappell, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8348 Traford Ln Ste 400, Springfield, VA 22152 Phone: 703-866-2110 | |
Rais A Khan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8348 Traford Ln, Suite 400, Springfield, VA 22152 Phone: 703-866-2100 Fax: 703-451-7539 | |
Dr. Benjamin A Adewale, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7011 Calamo St, #105, Springfield, VA 22150 Phone: 703-569-8028 Fax: 703-569-8085 | |
Zafar Abdur Rasheed, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8348 Traford Ln, 4th Floor, Springfield, VA 22152 Phone: 703-866-2100 |